A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C. (Q43048199)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2003

edit

Language	Label	Description	Also known as
English	A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C.	scientific article published in June 2003

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12798249

retrieved

12 November 2017

title

A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12798249

retrieved

12 November 2017

main subject

patient

0 references

chronic hepatitis

1 reference

based on heuristic

inferred from title

author

Bettina Hansen

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12798249

retrieved

12 November 2017

Volker Lohmann

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12798249

retrieved

12 November 2017

Bart L. Haagmans

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12798249

retrieved

12 November 2017

Ralf Bartenschlager

object named as

Ralf Bartenschlager

series ordinal

7

0 references

author name string

Jan M Vrolijk

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12798249

retrieved

12 November 2017

Artur Kaul

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12798249

retrieved

12 November 2017

Solko W Schalm

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12798249

retrieved

12 November 2017

publication date

1 June 2003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12798249

retrieved

12 November 2017

published in

Journal of Virological Methods

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12798249

retrieved

12 November 2017

volume

110

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12798249

retrieved

12 November 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12798249

retrieved

12 November 2017

page(s)

201-209

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12798249

retrieved

12 November 2017

cites work

Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficient initiation of HCV RNA replication in cell culture

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of alpha interferon on the hepatitis C virus replicon

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors affecting the measurement of cytokines in biological fluids: implications for their clinical measurement

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis C with high-dose interferon alpha-2b. A multicenter study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological assays for interferons

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Establishment of new and replacement World Health Organization International Biological Standards for human interferon alpha and omega

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble interferon-alpha receptor molecules are present in body fluids

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of cell lines carrying self-replicating hepatitis C virus RNAs

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900134-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0166-0934(03)00134-4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12798249

retrieved

12 November 2017

PubMed publication ID

12798249

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12798249

retrieved

12 November 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43048199&oldid=1590634148"